23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
Article excerpt
Highlighted: the sentence this signal was extracted from
SAN DIEGO, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced a new collaboration with 23XI Racing and their NASCAR Cup Series driver Tyler Reddick to encourage more people to recognize the signs of sleep apnea and seek diagnosis and treatment. In NASCAR, sustained concentration, physical endurance and split-second decisions can be the difference between winning and losing. Research shows that even one night of poor sleep can impair sustained attention and increase reaction time. 1 After being diagnosed with obstructive sleep apnea (OSA) and starting continuous positive airway pressure (CPAP) therapy in early 2026, Tyler went on to become the first driver in NASCAR Cup Series history to open a season with three consecutive victories, which included the Daytona 500. His experience highlights the performance advantage that treating his sleep apnea can provide. For years, Reddick dismissed his sleep apnea symptoms, including loud snoring, morning headaches, low energy and waking up feeling unrested. His experience reflects a broader challenge. OSA, the most common form of sleep apnea, impacts nearly 1 billion people globally 2, yet more than 80% of cases remain undiagnosed and untreated 3, often because symptoms are mistaken as normal. Reddick is...
Keep reading with a free account
The rest of this article, and every signal for ResMed, is in your free account.